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More  than  ever  before,  it  is  imperative 
to  find  effective  treatments  for  most  of 
our  psychiatric  disorders.  Imagine  that 
in  2020,  and  despite  a  widespread  use 
of  antidepressant  treatments,  the  World 
Health Organization projects the burden 
of depression to become second only to 
ischemic heart disease (Hirschfeld, 1998; 
Greden, 2001). In fact, of the top ten causes 
for years lived in disability, three are psy-
chiatric  illnesses.  Depression  is  second, 
but alcoholism and dementia are promi-
nently featured too. Both bipolar disorder 
and  schizophrenia  will  also  continue  to 
cause significant suffering. These psychi-
atric conditions are chronic and not fully 
responsive  to  treatments.  Patients  often 
relapse. The reasons for these dire projec-
tions lie primarily in the phenomenologi-
cal approach of our diagnostic approach, 
our incomplete understanding of the het-
erogeneous pathophysiology of psychiat-
ric illnesses and the limited efficacy of our 
therapeutic arsenals.
Modern scientific conceptualization of 
brain functions and localizations began to 
emerge from animal experiments, cadaver 
dissections, and clinical observations con-
ducted by Broca (1865),  Jackson (1873), 
and others in the mid 19th century. Ideas 
of  regional  brain  functional  localization 
and electrochemical neuronal transmission 
would later evolve into the contemporary 
neuronal network models that guide and 
inform much of the current applications 
of somatic treatments in neuropsychiatry. 
Over the past two decades, the rate of evo-
lution of imaging technology and of study 
design has been breathtaking. Such inves-
tigations  have  shifted  the  debate  from  a 
reductionist “phrenology-like” attributions 
of mental phenomena, including psychiat-
ric symptoms, to a broader dynamic inter-
play amongst various brain regions. Their 
utility in defining causation or providing 
tangible  diagnostic  tools  for  clinicians 
remain  however  very  limited  (Bullmore 
and Fletcher, 2003). This may be due in 
large  part  to  restrictive  sampling,  study 
designs, and analytic methods. As the field 
matures, it has become apparent that the 
next challenges will have to integrate multi-
modal imaging techniques (Fox et al., 2009), 
cross-  validations with genetic studies (Frodl 
et al., 2008) and a departure from cross-
sectional studies, in addition to data pool-
ing to achieve representative sample sizes. 
The combination of transcranial magnetic 
stimulation (TMS) and other brain stimula-
tion tools, also offers unique opportunities 
to move away from the correlative nature of 
imaging results (Bohning et al., 1998).
The use of somatic interventions to con-
trol or treat mental symptoms dates back 
to ancient times (Tourney, 1967; Clower 
and Finger, 2002). Evidence for burr holes 
drilled into the skull to “cure the demons” 
goes back to the Neolithic age. The notions 
that  convulsions  and  fever  may  help 
mental disorders have been known since 
Hippocrates, while in medieval times, make-
believe surgeries were performed to extract 
the “stone of madness.” The current status 
of non-pharmacological brain stimulation 
therapies to treat psychiatric conditions is 
also rapidly evolving. Research applications 
range from the benign (transcranial direct 
current  stimulation,  tDCS)  (Been  et  al., 
2007) to the invasive (deep brain stimula-
tion, DBS) (Benabid et al., 2003) and cover 
a wide spectrum of disorders. Convulsive 
and sub-convulsive targeted brain stimu-
lation treatments are inherently different 
from  pharmacological  interventions.  An 
electrically  stimulated  cell  will  primarily 
produce  a  restricted  range  of  responses 
inherent to its functionality (Ranck, 1975; 
Nahas  et  al.,  2003a).  Brain  stimulation 
modulates the system’s endogenous respon-
siveness and presumably, when delivered 
appropriately,  allows  it  to  recruit  adap-
tive  strategies.  Random  or  deterministic 
influences  (e.g.,  electrical  stimuli,  object 
presentation,  or  emotional  deprivation) 
on biological   systems have been shown to 
produce variable results depending on the 
type, intensity, frequency, and threshold of 
the stimulus. Long term potentiation (LTP) 
or long term depression (LTD) can alter 
synaptic plasticity and learning (Iadorola 
et al., 1986; Buzsaki et al., 1987; Huang et al., 
2005). An optimal amount of added energy, 
whether it is electrical stimulation or “simu-
lated noise,” can enhance the detection of 
a weak signal, a phenomena known as sto-
chastic resonance (Huber et al., 2003). As 
it stands electroconvulsive therapy (ECT) 
remains the most widely adopted clinical 
brain stimulation therapy. And while effi-
cacious, the relapse rates associated with it 
are very high. Both TMS and vagus nerve 
stimulation (VNS) are US FDA approved 
for  depression  and  DBS  is  approved  for 
obsessive  compulsive  disorder  (OCD) 
under a humanitarian device exemption. 
But TMS is an acute treatment for mild to 
moderate TRD (Oreardon et al., 2007), but 
not in TR-BD (Nahas et al., 2003b; George 
et al., 2009) and little is known about its 
role in maintenance therapy (Janicak et al., 
2007). VNS on the other hand is a surgical 
procedure that delivers chronic treatment, 
is associated with relatively low relapse rates 
(Nahas et al., 2005) but is not supported by 
Class 1 evidence (Nahas et al., 2003b). The 
open reports of continuous high frequency 
DBS in depression and Tourette’s syndrome 
and epidural cortical stimulation in depres-
sion are encouraging but preliminary.
One of the recurring themes within each 
of the techniques is the currently inadequate 
understanding of the translational neuro-
biological effects of the “use parameters.” 
The  future  of  this  promising  field  will 
undoubtedly involve better translating the 
knowledge gained from preclinical cellular 
and non-human animal studies into clini-
cal brain stimulation therapeutic uses. The 
challenge we face in developing these new 
treatments would be to maintain a kalei-
doscopic  perspective  between  the  global Frontiers in Psychiatry  |  Neuropsychiatric Imaging and Stimulation    August 2010  | Volume 1  | Article 25  |  2
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Neural connectivity and neuromodula-
tion have become integral frameworks by 
which the field conceptualizes neuropsychi-
atric diseases and treatment interventions. 
But a fundamental challenge remains: how 
do we relate the dynamic interplay among 
brain regions to understand cognitive, emo-
tional, or behavioral regulation to effectively 
treat our patients and improve their qual-
ity of life. I dare to think that the future 
is promising.
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